Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02155400 · ClinicalTrials.gov registry record · NA
Thermal Compression Device for Maintenance of Perioperative Normothermia
A NA study of Hypothermia, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT02155400: Completed NA study of Hypothermia, sponsored by Stanford University.
NCT02155400 is a NA study of Hypothermia that has completed, run by Stanford University. The registered enrollment target is 37 participants, below the 45-participant average among 9 other Hypothermia trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02155400, a NA study of Hypothermia, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
Getting cold (not maintaining normothermia) around surgery (perioperative period) leads to many negative outcomes for patients including increased wound complications, abnormal heart rhythms and increased blood loss. These all lead to increased length of hospital stay and higher requirements for post operative monitoring. These add to around $3500 of extra costs per patient. The investigators aim to study the effects of a warming device, placed around the patient's legs and/or feet, to determine it's safety, efficacy and eventually compare to the current gold standard of a forced air warming blanket. Forced air warming has been associated with the spread of germs over the surgical field. Hence the need for warming equipment that won't do that.
Primary Outcome
average calculated looking for presence of hypothermia (below 36 deg core temp) During surgery, the patient will have their core temperature continuously monitored either via esophageal , tympanic and if available bladder (routine intraoperative monitoring)
Conditions Studied
Interventions
- DEVICE Bair Hugger
- DEVICE Prototype / Experimental device
Study Locations (1)
California
- Stanford University Hopspital - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT02155400 record still lists
NCT02155400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 45-participant average among 9 other Hypothermia trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Hypothermia appearing as the primary indexed condition, and to 2 interventions - of which Bair Hugger is the first listed.
NCT02155400 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02155400 about?
NCT02155400 is a clinical study titled "Thermal Compression Device for Maintenance of Perioperative Normothermia". Getting cold (not maintaining normothermia) around surgery (perioperative period) leads to many negative outcomes for patients including increased wound complications, abnormal heart rhythms and increased blood loss. These all lead to increased length of hospital stay and higher requirements for pos...
What is the current status of trial NCT02155400?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2014-08. Estimated completion is 2016-05.
What conditions does trial NCT02155400 study?
This clinical trial studies the following conditions: Hypothermia.
What interventions are being tested in trial NCT02155400?
The interventions under investigation include: Bair Hugger (DEVICE), Prototype / Experimental device (DEVICE).
Who is sponsoring clinical trial NCT02155400?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02155400 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypothermia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02155400's enrollment target sits among peer trials
37 5th of 9 higher than 5 of 9 other Hypothermia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypothermia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Blood Warming in Preterm Infants to Decrease Hypothermia
RECRUITING · NA
-
Neonatal Warming to Prevent Hypothermia
COMPLETED · NA
-
Hypothermia to Treat Severe Brain Injury
COMPLETED · NA
-
Comparison of Bi-environmental Conditions During Occupational Related Activity
COMPLETED · NA
-
Optimal Positioning of Nasopharyngeal Temperature Probes: A Prospective Cohort Study
COMPLETED · NA
-
Safety and Performance Monitoring During Occupational Work II
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia